REMI - Remedent, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.26
0.00 (0.00%)
At close: 2:09PM EST
Stock chart is not supported by your current browser
Previous Close0.26
Open0.26
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.26 - 0.26
52 Week Range0.14 - 0.40
Volume10,430
Avg. Volume5,956
Market Cap5.199M
Beta-0.06
PE Ratio (TTM)6.50
EPS (TTM)0.04
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.50
Trade prices are not sourced from all markets
  • Remedent Inc. :REMI-US: Earnings Analysis: Q2, 2018 By the Numbers : December 6, 2017
    Capital Cube4 days ago

    Remedent Inc. :REMI-US: Earnings Analysis: Q2, 2018 By the Numbers : December 6, 2017

    Categories: Yahoo FinanceGet free summary analysis Remedent Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Remedent Inc. – DENTSPLY SIRONA, Inc., BIOLASE, Inc., Milestone Scientific Inc. and Align Technology, Inc. (XRAY-US, BIOL-US, MLSS-US and ALGN-US) that have also reported for this period. Highlights Summary ... Read more (Read more...)

  • Remedent Inc. :REMI-US: Earnings Analysis: Q1, 2018 By the Numbers : August 17, 2017
    Capital Cube4 months ago

    Remedent Inc. :REMI-US: Earnings Analysis: Q1, 2018 By the Numbers : August 17, 2017

    Categories: Yahoo FinanceGet free summary analysis Remedent Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Remedent Inc. – DENTSPLY SIRONA, Inc., BIOLASE, Inc., Milestone Scientific Inc. and Align Technology, Inc. (XRAY-US, BIOL-US, MLSS-US and ALGN-US) that have also reported for this period. Highlights Summary ... Read more (Read more...)

  • Remedent Inc. :REMI-US: Earnings Analysis: Q4, 2017 By the Numbers : August 4, 2017
    Capital Cube4 months ago

    Remedent Inc. :REMI-US: Earnings Analysis: Q4, 2017 By the Numbers : August 4, 2017

    Categories: Yahoo FinanceGet free summary analysis Remedent Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Remedent Inc. – Align Technology, Inc. (ALGN-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.54 million, Net Earnings of USD 0.60 million. Gross ... Read more (Read more...)

  • Marketwired8 months ago

    Remedent to launch and distribute the Condor Intra Oral Dental Scanner in North America

    Remedent, Inc. , an international company specializing in research, development, and manufacturing of oral care and cosmetic dentistry products, is pleased to announce it has entered into an agreement......

  • Marketwired9 months ago

    Remedent effectively deleverages its balance sheet

    Remedent, Inc. is pleased to announce that it has entered into an agreement in relation to a settlement of secured debt extended by Excelsior Medical Co., Ltd and Asia Best Healthcare...

  • Marketwired9 months ago

    Remedent Appoints Arrowhead Business and Investment Decisions

    Remedent, Inc. is pleased to announce the appointment of Arrowhead Business and Investment Decisions, LLC to advise on investor relations and shareholder communications.Arrowhead is a New...